Cell and Gene Therapy CMO and CDMO Facilities
Database of 124 Cell and Gene Therapy CMOs / CDMOs as of 12 July 2019, including 87 companies and 37 academic or government facilities.
This is a global database of facilities that provide (mostly or exclusively) services as contract manufacturing organizations (CMO) and/or contract development and manufacturing organizations (CDMO) for the cell and gene therapy industry worldwide.
Included: Manufacturers of therapeutic cell products (unmodified or gene-modified), iPS cell lines for therapeutic products, viral vectors and DNA plasmids for cell and gene therapy industry.
Excluded: Contract research organizations (CROs) not performing manufacture of the therapeutic product, vendors of supplies (reagents, devices, etc.)
Update: This list is updated every few months. Since May 2019, a column was added to track Mergers & Acquisitions or name changes for companies in this space.
For each company:
- Facility name
- Link to facility website if available
- Country of origin
- CMO/CDMO service expertise
- Mergers & Acquisitions, Notes
- File has separate lists for CMO/CDMO that are Industry versus Academic/ Government facilities.
|SAMPLE Cell and Gene Therapy CMO and CDMO Facilities||11.3 KB|